Standout Papers
Citation Impact
Citing Papers
Tibetans living at sea level have a hyporesponsive hypoxia-inducible factor system and blunted physiological responses to hypoxia
2013 StandoutNobel
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension
2006
Exercise-Induced Pulmonary Arterial Hypertension
2008
Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia.
2006
Criteria for diagnosis of exercise pulmonary hypertension
2015
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
Borderline Mean Pulmonary Artery Pressure in Patients With Systemic Sclerosis: Transpulmonary Gradient Predicts Risk of Developing Pulmonary Hypertension
2012
HIF2α–arginase axis is essential for the development of pulmonary hypertension
2016
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
How the left and right sides of the heart, as well as pulmonary venous drainage, adapt to an increasing degree of head-up tilting in hypertrophic cardiomyopathy: differences from the normal heart
2000
Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension
2011 StandoutNobel
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
2013
Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
2017
Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation
2011 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Chemoreflex physiology and implications for sleep apnoea: insights from studies in humans
2014
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension
2012
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
2009
Pulmonary hypertension in chronic obstructive pulmonary disease
2003
Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses
2006
Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension
2016
Pulmonary hypertension in sickle cell disease
2015
Pulmonary veno-occlusive disease
2016
Outcomes of Pulmonary Endarterectomy Surgery
2006
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
2011
Acute Oxygen-Sensing Mechanisms
2005
Medical Therapy For Pulmonary Arterial Hypertension
2004
Chronic Thromboembolic Pulmonary Hypertension
2013
Assessment of Operability in Chronic Thromboembolic Pulmonary Hypertension
2006
Demographics and Outcomes of Patients Diagnosed With Pulmonary Hypertension With Pulmonary Capillary Wedge Pressures 16 to 18 mm Hg
2012
Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension
2007
Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors
2013 StandoutNobel
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
2009
The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access
2005
The Acute Respiratory Distress Syndrome
2000 Standout
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
2011
Pulmonary Arterial Hypertension
2009
Spermidine/Spermine-N1-Acetyltransferase 2 Is an Essential Component of the Ubiquitin Ligase Complex That Regulates Hypoxia-inducible Factor 1α
2007 StandoutNobel
Pediatric Pulmonary Hypertension
2013
Effect of Orally Active Prostacyclin Analogue on Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension Without Major Vessel Obstruction
2003
Pulmonary Veno-Occlusive Disease
2008
Utility of Right Ventricular Tei Index in the Noninvasive Evaluation of Chronic Thromboembolic Pulmonary Hypertension Before and After Pulmonary Thromboendarterectomy
2009
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States
2010
Pulmonary Hypertension Due to Left Heart Diseases
2013
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients
2012
Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy
2003
Clinical classification of pulmonary hypertension
2004 Standout
NO: COPD and beyond
1997
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
2010
Primary Pulmonary Hypertension
1997 Standout
Pulmonary Arterial Hypertension
2006
The prognostic impact of thyroid function in pulmonary hypertension
2016
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
2010
Occult alveolar haemorrhage in pulmonary veno-occlusive disease
2005
Pulmonary Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension
2006
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
2006
Physiological aspects of high-altitude pulmonary edema
2005
Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective
2012
No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers
2009
Early detection of pulmonary arterial hypertension
2014
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome
2008
Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension
2004
Combination of Echocardiographic and Pulmonary Function Test Measures Improves Sensitivity for Diagnosis of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: Analysis of 2 Cohorts
2013
Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy
2005
Long-term Effect of Almitrine Bismesylate in Patients with Hypoxemic Chronic Obstructive Pulmonary Disease
1989
An Alternative Echocardiographic Method to Estimate Mean Pulmonary Artery Pressure: Diagnostic and Clinical Implications
2009
Congenital Heart Disease Associated Pulmonary Arterial Hypertension
2007
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
2011
Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients
2018
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
2009
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
2001
Pulmonary Hypertension Associated with Left-Sided Heart Disease
2007
Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients
2000
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics
1991
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
2005
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
2006 StandoutNobel
Mid-term results of surgery for chronic thromboembolic pulmonary hypertension
2009
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Echocardiography in Chronic Thromboembolic Pulmonary Hypertension
2006
Pulmonary vascular disorders in portal hypertension
1998
Assessing right ventricular function: the role of echocardiography and complementary technologies
2006
Pulmonary Endarterectomy Improves Dyspnea by the Relief of Dead Space Ventilation
2010
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
2007
Acute Pancreatitis
1994 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Pulmonary–Hepatic vascular Disorders (PHD)
2004
Mid-Term Efficacy of Beraprost, an Oral Prostacyclin Analog, in the Treatment of Distal CTEPH: A Case Control Study
2006
Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease
1997
The echocardiographic assessment of the right ventricle: what to do in 2010?
2010
High-Altitude Illness
2001 Standout
Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension
2007
Portopulmonary Hypertension
2008
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
1993
Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension
2008
A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension
2007
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial
2008
Two temporal components within the human pulmonary vascular response to ∼2 h of isocapnic hypoxia
2004
Prognostic value of the pre-transplant diastolic pulmonary artery pressure–to–pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension
2013
Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension: An Evolving Treatment Paradigm
2006
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension
2006
Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension
2006
The role of combination therapy in managing pulmonary arterial hypertension
2014
Delay in Recognition of Pulmonary Arterial Hypertension
2011
Echocardiographic Indexes for the Non-Invasive Evaluation of Pulmonary Hemodynamics
2010
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Peripheral Chemoreceptors: Function and Plasticity of the Carotid Body
2012
Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
2014
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
2007
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
2013
Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude
2005
Pulmonary hypertension due to left heart disease
2018
Survival in Schistosomiasis-Associated Pulmonary Arterial Hypertension
2010
Chronic thromboembolic pulmonary hypertension
2014
Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema
2000
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Brief Report: Effect of ambrisentan treatment on exercise‐induced pulmonary hypertension in systemic sclerosis: A prospective single‐center, open‐label pilot study
2012
Ambrisentan, a Non‐peptide Endothelin Receptor Antagonist
2006
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers
2006
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
2011
Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1α (HIF-1α) for Lysosomal Degradation
2013 StandoutNobel
Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure
2005
Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality
2017
Pulmonary Complications of Sickle Cell Disease
2012
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
2006
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Perfusion Techniques for Pulmonary Thromboendarterectomy Under Deep Hypothermia Circulatory Arrest: A Case Series
2006
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension
2011
Pulmonary Vascular Reactivity and Prognosis in Patients With Chronic Thromboembolic Pulmonary Hypertension
2009
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
2002 StandoutNobel
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007
Physiology meets biophysics: Visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP
2002 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Pulmonary Arterial Hypertension
2006
The Heart and Pulmonary Circulation at High Altitudes
2007
Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization
2013
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
2003 StandoutNobel
The angiopietin-1–Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice
2009
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
Pathophysiology of Sleep Apnea
2010 Standout
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Hemodynamic Responses to Rapid Saline Loading
2012
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
2005
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Technique and outcomes of pulmonary endarterectomy surgery.
2008
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
The Acute Respiratory Distress Syndrome
1996 Standout
Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients
2012
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Chronic thromboembolic pulmonary hypertension
2004
Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
2013
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension
2008
Hypoxemia in patients with COPD: cause, effects, and disease progression
2011
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension
2003
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
2003
Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension
2007
Works of Robert Naeije being referenced
Is nasogastric suction necessary in acute pancreatitis?
1978
Pulmonary Hypertension and Chronic Mountain Sickness
2013
Echocardiographic Prediction of Pre- versus Postcapillary Pulmonary Hypertension
2014
Nature of pulmonary hypertension in congestive heart failure. Effects of cardiac transplantation.
1994
Right ventricular function in scleroderma-related pulmonary hypertension
2008
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
2010
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
2012
How Prostacyclin Improves Cardiac Output in Right Heart Failure in Conjunction with Pulmonary Hypertension
2007
Pulmonary and Extrapulmonary Contributors to Hypoxemia in Liver Cirrhosis
1989
Right Ventricular Load at Exercise Is a Cause of Persistent Exercise Limitation in Patients With Normal Resting Pulmonary Vascular Resistance After Pulmonary Endarterectomy
2010
Prevalence of diabetic retinopathy in children and adolescents with type-1 diabetes attending summer camps in France
2007
Right Heart Adaptation to Pulmonary Arterial Hypertension
2013
Pulmonary Circulation at High Altitude
1997
Prostaglandin E 1 in the Adult Respiratory Distress Syndrome: Benefit for Pulmonary Hypertension and Cost for Pulmonary Gas Exchange
1989
Exercise testing in pulmonary arterial hypertension and in chronic heart failure
2004
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
2003
Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan
2006
Tissue Doppler Imaging Evaluation of Cardiac Adaptation to Severe Pulmonary Hypertension
2007
Hepatopulmonary syndrome and portopulmonary hypertension
2003
Pathobiology of pulmonary arterial hypertension
2002
Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans
2003
Diagnosis and Assessment of Pulmonary Arterial Hypertension
2009
End points in pulmonary arterial hypertension: the way forward
2004
Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH
2012
Altered synchrony of right ventricular contraction in borderline pulmonary hypertension
2017
Physiology of the Pulmonary Circulation and the Right Heart
2013
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
2009
The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease
2012
MEDICAL THERAPY OF PULMONARY HYPERTENSION
2001
Feasibility of Routine Pulmonary Arterial Impedance Measurements in Pulmonary Hypertension
2004
Exercise Stress Echocardiography of the Pulmonary Circulation
2012
Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation
2014
Ambrisentan Therapy for Pulmonary Arterial Hypertension
2005
Echocardiography in Pulmonary Arterial Hypertension: from Diagnosis to Prognosis
2012
High-Altitude Pulmonary Edema With Primary Pulmonary Hypertension
1996
False-positive diagnosis of pulmonary hypertension by Doppler echocardiography
1998
Endothelin receptor antagonists
2005
Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure*
2006
Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension
2013
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
2004
Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure*
2004
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component
2016
Efficacy of Long-term Subcutaneous Treprostinil Sodium Therapy in Pulmonary Hypertension
2006
Prevention of Hemodilution-Induced Inhibition of Hypoxic Pulmonary Vasoconstriction by N-Acetylcysteine in Dogs
2004
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
2006
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial
2002
Pulmonary Hypertension and Right Heart Failure in Chronic Obstructive Pulmonary Disease
2005
Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension
2016
Pulmonary hypertension and the right ventricle in hypoxia
2013
Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders
2006
Transitioning From IV Epoprostenol to Subcutaneous Treprostinil in Pulmonary Arterial Hypertension
2002
Pulmonary hypertension in COPD
2008
Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension
2006
Reading Pulmonary Vascular Pressure Tracings. How to Handle the Problems of Zero Leveling and Respiratory Swings
2014
Site of Pulmonary Vasodilation by Inhaled Nitric Oxide in Microembolic Lung Injury
1997
Exercise-induced Pulmonary Hypertension
2013
Prognostic Significance of Sympathetic Nervous System Activation in Pulmonary Arterial Hypertension
2010
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension
2002 Standout
Effect of Bosentan and Sildenafil Combination Therapy on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the COMPASS-2 Study
2014
Acute hemodynamic effects of controlled oxygen therapy in decompensated chronic obstructive pulmonary disease
1984
Improvement in Ventilation-Perfusion Matching by Almitrine in COPD
1983
Doppler assessment of hypoxic pulmonary vasoconstriction and susceptibility to high altitude pulmonary oedema.
1995
Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension
2004
Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension
2003
Pulmonary Hemodynamics in Liver Cirrhosis
1985
Signaling Molecules in Overcirculation-Induced Pulmonary Hypertension in Piglets
2004
Oxygen delivery in acute exacerbation of chronic obstructive pulmonary disease. Effects of controlled oxygen therapy.
1981
Effects of Vasodilators on Hypoxic Pulmonary Vasoconstriction in Normal Man
1982
Gas exchange during acute respiratory failure in patients with chronic obstructive pulmonary disease
1996
Problems of High Altitude Medicine and Biology
2007
Partitioning of Pulmonary Vascular Resistance in Primary Pulmonary Hypertension 11This study was supported by Grant 3.4517.95 from the Fonds de la Recherche Scientifique Médicale Belgium and by the Belgian Foundation for Cardiac Surgery, Brussels. Sophia Abdel Kafi was a fellow of the Erasmus Foundation, Brussels.
1998
Dissociation entre ventilation et gaz du sang sous perfusion d'almitrine chez des patients porteurs de bronchopneumopathie chronique obstructive(B.P.C.O.)
1980
Preoperative Partitioning of Pulmonary Vascular Resistance Correlates With Early Outcome After Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension
2003
Pulmonary vascular resistance
2003
Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema
2006
Hypoxic Pulmonary Vasoconstriction in Liver Cirrhosis
1981
Effects of Nifedipine on Ventilation/Perfusion Matching in Primary Pulmonary Hypertension
1983
Pulmonary Vascular Hemodynamic Response to Exercise in Cardiopulmonary Diseases
2013
Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude
2000
Single-beat estimation of right ventricular end-systolic pressure-volume relationship
2003
Effects of almitrine in decompensated chronic respiratory insufficiency.
1981
High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure
2001
Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure
2017
Increased Peripheral Chemoreceptors Sensitivity and Exercise Ventilation in Heart Transplant Recipients
2006